Creative Planning
- SEC CIK
- 0001540235
- Latest filing
- Aug 13, 2026
IMDX holding history
Insight Molecular Diagnostics Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMDX overviewAll 13F holders of IMDXFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −607−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q2 2023 | 12,136 | $2.79K | <0.1% | +12,136 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −18,609−100.0% | Sold out | Holders |
| Q4 2022 | 18,609 | $5.97K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 18,609 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 18,609 | $17.0K | <0.1% | +3,300+21.6% | Added | Holders |
| Q1 2022 | 15,309 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 15,309 | $33.0K | <0.1% | +15,309 | New | Holders |